Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Review of assessment of total androgen blockade as treatment of metastatic prostate cancer.

× No keyword cloud information.

24 in total

1. International symposium: Hormonal Therapy of Prostatic Diseases: Basic and Clinical Aspects. Milano, Italy, April 6-8, 1987. Abstracts of lectures and free communications.

Authors:
Journal: J Endocrinol Invest Date: 1987 Impact factor: 4.256

2. Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro.

Authors: M E Harper; A Pike; W B Peeling; K Griffiths
Journal: J Endocrinol Date: 1974-01 Impact factor: 4.286

3. Ketoconazole therapy in advanced prostatic cancer.

Authors: J Trachtenberg
Journal: J Urol Date: 1984-07 Impact factor: 7.450

4. Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo.

Authors: J M Brisset; L Boccon-Gibod; H Botto; M Camey; G Cariou; J M Duclos; F Duval; D Gontiès; R Jorest; L Lamy
Journal: Prog Clin Biol Res Date: 1987

5. Regulation and compartmentalization of androgens in rat prostate and muscle.

Authors: W Bartsch; C Knabbe; K D Voigt
Journal: J Steroid Biochem Date: 1983-07 Impact factor: 4.292

6. Treatment of advanced prostatic cancer, resistant to conventional therapy, with aminoglutethimide.

Authors: R Murray; P Pitt
Journal: Eur J Cancer Clin Oncol Date: 1985-04

7. Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer.

Authors: G Williams; D J Kerle; H Ware; A Doble; H Dunlop; C Smith; J Allen; T Yeo; S R Bloom
Journal: Br J Urol Date: 1986-02

8. Relationship between human prostatic epithelial cell protein synthesis and tissue dihydrotestosterone level.

Authors: J Geller; J Liu; J Albert; W Fay; C C Berry; P Weis
Journal: Clin Endocrinol (Oxf) Date: 1987-02 Impact factor: 3.478

9. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy.

Authors: J Geller; J D Albert; D A Nachtsheim; D Loza
Journal: J Urol Date: 1984-10 Impact factor: 7.450

10. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors: R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal: Br J Cancer Date: 1976-12 Impact factor: 7.640

1 in total

Review 1. Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.

Authors: Elahe A Mostaghel; Bruce Montgomery; Peter S Nelson
Journal: Urol Oncol Date: 2009 May-Jun Impact factor: 3.498

1 in total